XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Parent
Common stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance at Dec. 25, 2021 $ 53,010              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income 4,020              
Other comprehensive income (loss) (3,585)              
Dividends declared to noncontrolling interests (3,525)              
Purchase of redeemable noncontrolling interest (15,000)              
Adjustment to noncontrolling interest fair value 7,507              
Ending balance at Dec. 31, 2022 42,427              
Beginning balance (in shares) at Dec. 25, 2021     50,480,000          
Beginning balance at Dec. 25, 2021 2,538,982 $ 2,534,820 $ 505 $ 1,718,304 $ 980,751 $ (164,740) $ 0 $ 4,162
Beginning balance (in shares) at Dec. 25, 2021             0  
Increase (Decrease) in Stockholders' Equity                
Net income 488,588 486,226     486,226     2,362
Other comprehensive income (loss) (97,317) (97,317)       (97,317)    
Dividends declared to noncontrolling interest (1,739)             (1,739)
Adjustment to noncontrolling interest fair value (7,507) (7,507)   (7,507)        
Issuance of stock under employee compensation plans (in shares)     594,000          
Issuance of stock under employee compensation plans 25,105 25,105 $ 5 25,100        
Purchase of treasury shares (in shares)             130,000  
Purchase of treasury shares (38,651) (38,651)         $ (38,651)  
Retirement of treasury shares (in shares)     (130,000)       (130,000)  
Retirement of treasury shares 0 0 $ (1) (4,574) (34,076)   $ 38,651  
Stock-based compensation 73,617 73,617   73,617        
Ending balance (in shares) at Dec. 31, 2022     50,944,000          
Ending balance at Dec. 31, 2022 2,981,078 2,976,293 $ 509 1,804,940 1,432,901 (262,057) $ 0 4,785
Ending balance (in shares) at Dec. 31, 2022             0  
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income 3,492              
Other comprehensive income (loss) (1,200)              
Dividends declared to noncontrolling interests (2,378)              
Adjustment of redeemable noncontrolling interests to redemption value (5,694)              
Purchase of redeemable noncontrolling interest (24,148)              
Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest (1,151)              
Acquisition of redeemable noncontrolling interest 45,374              
Ending balance at Dec. 30, 2023 56,722              
Increase (Decrease) in Stockholders' Equity                
Net income 476,878 474,624     474,624     2,254
Other comprehensive income (loss) 65,630 65,630       65,630    
Dividends declared to noncontrolling interest (1,645)             (1,645)
Adjustment to noncontrolling interest fair value 5,694 5,694   5,694        
Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest 1,151 1,151   1,151        
Issuance of stock under employee compensation plans (in shares)     499,000          
Issuance of stock under employee compensation plans 25,597 25,597 $ 5 25,592        
Purchase of treasury shares (in shares)             105,000  
Purchase of treasury shares (24,155) (24,155)         $ (24,155)  
Retirement of treasury shares (in shares)     (105,000)       (105,000)  
Retirement of treasury shares 0 0 $ (1) (3,847) (20,307)   $ 24,155  
Stock-based compensation $ 72,048 72,048   72,048        
Ending balance (in shares) at Dec. 30, 2023 51,338,000   51,338,000          
Ending balance at Dec. 30, 2023 $ 3,602,276 3,596,882 $ 513 1,905,578 1,887,218 (196,427) $ 0 5,394
Ending balance (in shares) at Dec. 30, 2023 0           0  
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income $ 1,095              
Other comprehensive income (loss) (2,851)              
Dividends declared to noncontrolling interests (12,580)              
Adjustment of redeemable noncontrolling interests to redemption value 10,688              
Purchase of redeemable noncontrolling interest (12,000)              
Adjustment of purchase price of Noveprim redeemable noncontrolling interest 52              
Ending balance at Dec. 28, 2024 41,126              
Increase (Decrease) in Stockholders' Equity                
Net income 24,196 22,203     22,203     1,993
Other comprehensive income (loss) (120,918) (120,918)       (120,918)    
Dividends declared to noncontrolling interest (1,938)             (1,938)
Adjustment to noncontrolling interest fair value (10,688) (10,688)   (10,688)        
Issuance of stock under employee compensation plans (in shares)     388,000          
Issuance of stock under employee compensation plans 23,878 23,878 $ 4 23,874        
Purchase of treasury shares (in shares)             585,000  
Purchase of treasury shares (119,175) (119,175)         $ (119,175)  
Share repurchase excise tax (570)              
Retirement of treasury shares (in shares)     (585,000)       (585,000)  
Retirement of treasury shares 0 0 $ (6) (22,418) (97,321)   $ 119,745  
Stock-based compensation $ 69,891 69,891   69,891        
Ending balance (in shares) at Dec. 28, 2024 51,141,000   51,141,000          
Ending balance at Dec. 28, 2024 $ 3,466,952 $ 3,461,503 $ 511 $ 1,966,237 $ 1,812,100 $ (317,345) $ 0 $ 5,449
Ending balance (in shares) at Dec. 28, 2024 0           0